Navigation Links
PI-103 Effective against Brain Cancer

According to the researchers at the University of California, San Francisco (UCSF) they have identified a class of compounds that prevents the growth of brain cancer. // The compound called the PI-103 acts as a potent drug candidate against lethal brain tumor. In animal studies (mice) with human glioma grafts the drug is found to be potent against proliferating cancer cells. The unique effectiveness of PI-103 stems from its ability to attack two separate steps in the series of signals that trigger the spread of cancer. The dual blockade proved to be a safe and effective inhibitor of cancer cell proliferation in mice with the human tumors, the scientists found.

The glioma research is being published online May 15 by the journal Cancer Cell. A description of the strategy used to identify the molecular level action of the inhibitors was published online by the journal Cell on April 27. Food and Drug Administration approval five years ago of the cancer drug Gleevec marked a promising new strategy against cancer. Gleevec was the first drug on the market designed to block ubiquitous signaling molecules called protein kinases – enzymes known to trigger normal cell proliferation, and in the case of cancer, the growth of tumors.

Another group of kinases, called lipid kinases are now emerging as important new targets, especially PI3 alpha kinase, an enzyme often found to be overactive in brain, breast, colon and stomach cancers. But the sheer number of related kinases – 15 in the PI3 kinase family alone – and uncertainty about how each acts in the body – has stalled progress. Broad spectrum drugs that inhibit many related kinases inevitably cause toxicity and are poor drug candidates. To overcome this hurdle, Kevan Shokat, PhD, a Howard Hughes Medical Institute investigator at UCSF, and Zachary Knight, a postdoctoral fellow in his lab, developed a strategy to systematically inhibit many different but related kinases to identify which ones might be prime t
'"/>




Page: 1 2 3

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Effective against Brain Cancer

(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ccording to a British Muslim scholar a special and...sh Muslims. Professor Aziz Sheikh of Edinburgh Uni...r better health for Muslims in United Kingdom. Wh...Medical Journal, professor reiterates the need for...
... recent study that appeared in the January/Februar...General Dentistry's (AGD) clinical, peer-reviewed ... pacifier use. "Contrary to popular belief, ther...from sucking on pacifiers," says Jane Soxman, DDS,...
...ost children do not grow up without the advice to ...tion and most of us know it. A novel study has fou... only when they are consumed at the appropriate ti...ty of Auckland looked into the dietary habits of c...
... new study published in the December 2006 issue of... at The Weight Control and Diabetes Research Cente... suggests that as teens enter adulthood - they are...ase their fast food consumption - both behaviors l...
Other Medicine News:Health News:Pacifier Use Reduces Incidence of SIDS: Study 2Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 2Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 3
(Date:8/26/2008)... Coupled with Innovative Manufacturing - Has Poten...ic Preparedness, ROCKVILLE, Md., Aug. 26 /PRNewsw...nnounced today favorable results from the second s...s pandemic influenza virus-like,particle (VLP) vac...n an,adjuvant, induced robust neutralizing antibod...
(Date:8/25/2008)... Stem Cells Found in Menstrual Blood May Offer Lon...me-Pressed Women, OLDSMAR, Fla., Aug. 25 /PRNewsw... women would agree that there never seems to be en...pends on doing something just,for herself usually ...ers.,This reality has led many women in need of qu...
(Date:8/25/2008)...LLS, Mass., Aug. 25 /- Joseph F. Finn...Spherics, Inc. ("Spherics") for,the benefit of cre...tellectual property will be sold at a sealed bid a...ed release formulation of Levodopa-Carbidopa that,...on,s disease, with global,sales estimated at appro...
(Date:8/25/2008)...alif., Aug. 25 /- Anthera Pharmaceuti...any developing,anti-inflammatory drugs, today anno...nt Acute coronary events with Near-term Cardiovasc...gned to examine the impact of,varespladib when adm...Coronary Syndrome (ACS) event., The FRANCIS trial...
Breaking Medicine Technology:Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Mylan Announces Appointment of M Fabiana Lacerca as Senior Vice President and Chief Compliance Officer 1305 1Mylan Announces Appointment of M Fabiana Lacerca as Senior Vice President and Chief Compliance Officer 1305 2Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 1Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 2Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 3Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 1302 4System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 1System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 2Common Foot Myths Trip Us Up 1298 1Common Foot Myths Trip Us Up 1298 2
... June 14, 2007) - Ambrilia,Biopharma Inc. (TSX:AMB...all molecules and peptides to treat infectious dis...ial Meeting today, during,which the data reported ...ibitors and recent developments were highlighted. ... Board, Mr. Frederic,Porte, and a progress report ...
...ewswire/ -- Results of the,Option (TOcilizumab Piv...trial, the first multinational Phase III study out...ctemra (either 4mg/kg,or 8mg/kg) plus methotrexate...mprovement in the signs and symptoms of moderate t...ients treated with,placebo and methotrexate, a cur...
Other Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
Corneal Trephine Punch - Stainless steel unit with titanium jaws, complete with PTFE cutting block. 1 reusable unit.
Corneal Marker - 8 blades, 2 sizes available: 7.0mm, 8.0mm. 1 piece per box
...ntrol you've come to demand in BD K-3000 microkera...keratome is built upon. , ,The BD K-4000 Micro...e front panel on the new console has been designed...ck., ,The BD K-4000 Microkeratome has been eng...
The 4.5/5.0 mm Cannulated Screw System is part of a series of modular systems developed by DePuy ACE for cannulated screws ranging from 3.5mm to 8.0mm. Complete with instruments, disposables and scre
Medicine Products: